TDYbio Logo
www.tdybio.com
P44/42 MAPK(ERK1/2) Mouse mAb(6C10)
Key facts:
Catalog NO:TDY493
Source :Mouse
Type:Monoclonal
Application:WB, IHC
Reactivity:H,R,M
Isotype:IgG1
MW(KDa):44/42
Alternative Names:MAPK, Mitogen-activated protein Kinase, PRKM2,MK01
Specifications:

Source

A Mouse Monoclonal antibody is prepared by immunizing synthetic peptide coupled to KLH.


Specificity

The P44/42 MAPK(ERK1/2) Mouse Monoclonal antibody can recognize endogenous P44/42 MAPK(ERK1/2) proteins.


 
Storage

Store at -20°C. Stable for one year from the date of shipment.


 
Concentration

1mg/ml in PBS, pH 7.4, containing 0.02% sodium azide and 50% glycerol.



Dilutions

WB 1:1,000-2,000     IHC  1:100-200   

(Optimal dilutions should be determined by the end user)

 

 

Background:
 
Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (Erk1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli including mitogens, growth factors, and cytokines and is an important target in the diagnosis and treatment of cancer.

 

Applications:

Western Blot

 

Western blot analysis of 1)Mouse Brain Tissue, 2) Rat Brain Tissue with P44/42 MAPK(ERK1/2) Mouse mAb TDY493 diluted at 1:2,000.

 

IHC

 

 

 

 

Immunohistochemical analysis of paraffin-embedded Human Breast Carcinoma using P44/42 MAPK (ERK1/2) (TDY493)Mouse mAb diluted at 1:200.

 

Contact information:
Company:BEI JING TDY BIOTECH CO.,LTD.
Orders:TDYbiotech@163.com
Website:http://www.tdybio.com
Telephone:010-80117836
Address:Zhen Xin Road 36.Changping Distict,Beijing
Reactivity: H-Human R-Rat M-Mouse Mk-Monkey Dg-Dog Ch-Chicken Hm-Hamster Rb-Rabbit Sh-Sheep Pg-Pig
Applications: WB-Western blot IHC-Immunochemistry IF-Immunofluorescence IP-Immunoprecipitation ChIP-Chormatin Immunoprecipitation
Please note: All products are"FOR RESEARCH USE ONLY.NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES".